Reovirus serotypes elicit distinctive patterns of recall immunity in humans

Journal of Virology

Volumn 82, Issue 15, 2008, Pages 7515-7523

  Douville, Renée N ^a   Su, Ruey Chyi ^a   Coombs, Kevin M ^a   Simons, F Estelle R ^a   Hayglass, Kent T ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD8 ANTIGEN; CD86 ANTIGEN; CHEMOKINE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNOREGULATION; IN VITRO STUDY; MOLECULAR RECOGNITION; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REOVIRUS; SEROTYPE; STATISTICAL SIGNIFICANCE; TH1 CELL; VIRAL GENETICS; VIRUS CULTURE; VIRUS DETECTION; VIRUS IMMUNITY; VIRUS MORPHOLOGY; VIRUS REPLICATION;

ADOLESCENT; ADULT; ANTIGENS, CD28; ANTIGENS, CD80; ANTIGENS, CD86; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; HUMANS; IMMUNOLOGIC MEMORY; INTERFERON TYPE II; INTERLEUKIN-10; LEUKOCYTES, MONONUCLEAR; MIDDLE AGED; ORTHOREOVIRUS, MAMMALIAN; T-LYMPHOCYTE SUBSETS;

MAMMALIAN ORTHOREOVIRUSES; ORTHOREOVIRUS;

EID: 47749123008     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00464-08     Document Type: Article

References (55)

1. Alain, T., K. Hirasawa, K. J. Pon, S. G. Nishikawa, S. J. Urbanski, Y. Auer, J. Luider, A. Martin, R. N. Johnston, A. Janowska-Wieczorek, P. W. Lee, and A. E. Kossakowska. 2002. Reovirus therapy of lymphoid malignancies. Blood 100:4146-4153.
2. Barkon, M. L., B. L. Haller, and H. W. Virgin IV. 1996. Circulating immunoglobulin G can play a critical role in clearance of intestinal reovirus infection. J. Virol. 70:1109-1116.
3. Becker, Y. 2003. Immunological and regulatory functions of uninfected and virus infected immature and mature subtypes of dendritic cells - a review. Virus Genes 26:119-130.
4. Berger, R. H., and J. A. Brody. 1967. Reovirus antibody patterns in Alaska. Am. J. Epidemiol. 86:724-735.
5. Bertram, E. M., W. Dawicki, and T. H. Watts. 2004. Role of T cell costimulation in anti-viral immunity. Semin. Immunol. 16:185-196.
6. Blazevic, V., C. M. Trubey, and G. M. Shearer. 2001. Analysis of the co-stimulatory requirements for generating human virus-specific in vitro T helper and effector responses. J. Clin. Immunol. 21:293-302.
7. Brewster, J., J. A. Oleszkiewicz, K. M. Coombs, and A. Nartey. 2005. Enteric virus indicators: reovirus versus poliovirus. J. Environ. Eng. 131:1010-1013.
8. Campbell, J. D., V. Gangur, F. E. Simons, and K. T. HayGlass. 2004. Allergic humans are hyporesponsive to a CXCR3 ligand-mediated Th1 immunity-promoting loop. FASEB J. 18:329-331.
9. Cashdollar, L. W., R. A. Chmelo, J. R. Wiener, and W. K. Joklik. 1985. Sequences of the S1 genes of the three serotypes of reovirus. Proc. Natl. Acad. Sci. USA 82:24-28.
10. Chen, D., and D. H. Rubin. 2001. Mucosal T cell response to reovirus. Immunol. Res. 23:229-234.
11. Coombs, K. M., S.-C. Mak, and L. D. Petrycky-Cox. 1994. Studies of the major reovirus core protein σ2: reversion of the assembly-defective mutant tsC447 is an intragenic process and involves back mutation of Asp-383 to Asn. J. Virol. 68:177-186.
12. Danthi, P., T. Kobayashi, G. H. Holm, M. W. Hansberger, T. W. Abel, and T. S. Dermody. 2008. Reovirus apoptosis and virulence are regulated by host cell membrane penetration efficiency. J. Virol. 82:161-172.
13. Douville, R. N., N. Bastien, Y. Li, P. Pochard, F. E. Simons, and K. T. HayGlass. 2006. Human metapneumovirus elicits weak IFN-gamma memory responses compared with respiratory syncytial virus. J. Immunol. 176:5848-5855.
14. Farone, A. L., S. M. O'Donnell, C. S. Brooks, K. M. Young, J. M. Pierce, J. D. Wetzel, T. S. Dermody, and M. B. Farone. 2006. Reovirus strain-dependent inflammatory cytokine responses and replication patterns in a human monocyte cell line. Viral Immunol. 19:546-557.
15. Fleeton, M., N. Contractor, F. Leon, J. He, D. Wetzel, T. Dermody, A. Iwasaki, and B. Kelsall. 2004. Involvement of dendritic cell subsets in the induction of oral tolerance and immunity. Ann. N. Y. Acad. Sci. 1029:60-65.
16. Fleeton, M. N., N. Contractor, F. Leon, J. D. Wetzel, T. S. Dermody, and B. L. Kelsall. 2004. Peyer's patch dendritic cells process viral antigen from apoptotic epithelial cells in the intestine of reovirus-infected mice. J. Exp. Med. 200:235-245.
17. Gaillard, R. K., and W. K. Joklik. 1980. The antigenic determinants of most of the proteins coded by the three serotypes of reovirus are highly conserved during evolution. Virology 107:533-536.
18. Gaillard, R. K., Jr., and W. K. Joklik. 1982. Quantitation of the relatedness of reovirus serotypes 1, 2, and 3 at the gene level. Virology 123:152-164.
19. Hayes, E. C., P. W. Lee, S. E. Miller, and W. K. Joklik. 1981. The interaction of a series of hybridoma IgGs with reovirus particles. Demonstration that the core protein lambda 2 is exposed on the particle surface. Virology 108:147-155.
20. Hoebe, K., E. M. Janssen, S. O. Kim, L. Alexopoulou, R. A. Flavell, J. Han, and B. Beutler. 2003. Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways. Nat. Immunol. 4:1223-1229.
21. Johansson, P. J., T. Sveger, K. Ahlfors, J. Ekstrand, and L. Svensson. 1996. Reovirus type 1 associated with meningitis. Scand. J. Infect. Dis. 28:117-120.
22. Kitchen, S. G., J. K. Whitmire, N. R. Jones, Z. Galic, C. M. Kitchen, R. Ahmed, and J. A. Zack. 2005. The CD4 molecule on CD8+ T lymphocytes directly enhances the immune response to viral and cellular antigens. Proc. Natl. Acad. Sci. USA 102:3794-3799.
23. Lal, R. B., D. L. Rudolph, C. S. Dezzutti, P. S. Linsley, and H. E. Prince. 1996. Costimulatory effects of T cell proliferation during infection with human T lymphotropic virus types I and II are mediated through CD80 and CD86 ligands. J. Immunol. 157:1288-1296.
24. Law, H. K., C. Y. Cheung, H. Y. Ng, S. F. Sia, Y. O. Chan, W. Luk, J. M. Nicholls, J. S. Peiris, and Y. L. Lau. 2005. Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells. Blood 106:2366-2374.
25. Leers, W. D., and K. R. Rozee. 1966. A survey of reovirus antibodies in sera of urban children. Can. Med. Assoc, J. 94:1040-1042.
26. Letvin, N. L., R. S. Kauffman, and R. Finberg. 1981. T lymphocyte immunity to reovirus: cellular requirements for generation and role in clearance of primary infections. J. Immunol. 127:2334-2339.
27. Major, A. S., D. H. Rubin, and C. F. Cuff. 1998. Mucosal immunity to reovirus infection. Curr. Top. Microbiol. Immunol. 233:163-177.
28. Matsuura, K., M. Ishikura, T. Nakayama, S. Hasegawa, O. Morita, K. Katori, and H. Uetake. 1993. Ecological studies on reovirus pollution of rivers in Toyama Prefecture. II. Molecular epidemiological study of reoviruses isolated from river water. Microbiol. Immunol. 37:305-310.
29. Matsuura, K., M. Ishikura, T. Nakayama, S. Hasegawa, O. Morita, and H. Uetake. 1988. Ecological studies on reovirus pollution of rivers in Toyama Prefecture. Microbiol. Immunol. 32:1221-1234.
30. Mendez, I. I., L. L. Hermann, P. R. Hazelton, and K. M. Coombs. 2000. A comparative analysis of freon substitutes in the purification of reovirus and calicivirus. J. Virol. Methods 90:59-67.
31. Minuk, G. Y., R. W. Paul, and P. W. Lee. 1985. The prevalence of antibodies to reovirus type 3 in adults with idiopathic cholestatic liver disease. J. Med. Virol. 16:55-60.
32. Norman, K. L., and P. W. Lee. 2005. Not all viruses are bad guys: the case for reovirus in cancer therapy. Drug Discov. Today 10:847-855.
33. Norman, K. L., and P. W. Lee. 2000. Reovirus as a novel oncolytic agent. J. Clin. Investig. 105:1035-1038.
34. Qiao, J., H. Wang, T. Kottke, C. White, K. Twigger, R. M. Diaz, J. Thompson, P. Selby, J. de Bono, A. Melcher, H. Pandha, M. Coffey, R. Vile, and K. Harrington. 2008. Cyclophosphamide facilitates antitumor efficacy against subcutaneous tumors following intravenous delivery of reovirus. Clin. Cancer Res. 14:259-269.
35. Ramadan, H. H., R. B. Meek, G. S. Dawson, G. A. Spirou, C. F. Cuff, and A. S. Berrebi. 2002. Histologic and immunologic observations of viral-induced rhinosinusitis in the mouse. Am. J. Rhinol. 16:61-67.
36. Richardson, S. C., R. F. Bishop, and A. L. Smith. 1994. Reovirus serotype 3 infection in infants with extrahepatic biliary atresia or neonatal hepatitis. J. Gastroenterol. Hepatol. 9:264-268.
37. Rinaldo, C. R., Jr., and P. Piazza. 2004. Virus infection of dendritic cells: portal for host invasion and host defense. Trends Microbiol. 12:337-345.
38. Rosen, L., H. E. Evans, and A. Spickard. 1963. Reovirus infections in human volunteers. Am. J. Hyg. 77:29-37.
39. Selb, B., and B. Weber. 1994. A study of human reovirus IgG and IgA antibodies by ELISA and Western blot. J. Virol. Methods 47:15-25.
40. Stefura, W. P., J. D. Campbell, R. Douville, M. J. Stinson, F. E. R. Simons, A. B. Becker, and K. T. HayGlass. 2008. Ultrasensitive ELISA for measurement of human cytokine responses in primary culture, p. 107-120. In M. G. Jones and P. Lympany (ed.), Allergy methods and protocols, series: methods in molecular medicine, vol. 138. Humana Press, Totowa, NJ.
41. Strong, J. E., M. C. Coffey, D. Tang, P. Sabinin, and P. W. Lee. 1998. The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus. EMBO J. 17:3351-3362.
42. Swallow, M. M., J. J. Wallin, and W. C. Sha. 1999. B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFalpha. Immunity 11:423-432.
43. Tai, J. H., J. V. Williams, K. M. Edwards, P. F. Wright, J. E. Crowe, Jr., and T. S. Dermody. 2005. Prevalence of reovirus-specific antibodies in young children in Nashville, Tennessee. J. Infect. Dis. 191:1221-1224.
44. Terheggen, F., E. Benedikz, P. H. Frissen, and K. Brinkman. 2003. Myocarditis associated with reovirus infection. Eur. J. Clin. Microbiol. Infect. Dis. 22:197-198.
45. Thirukkumaran, C. M., J. M. Luider, D. A. Stewart, T. Alain, J. A. Russell, I. A. Auer, P. Forsyth, and D. G. Morris. 2005. Biological purging of breast cancer cell lines using a replication-competent oncolytic virus in human stem cell autografts. Bone Marrow Transplant. 35:1055-1064.
46. Thirukkumaran, C. M., J. M. Luider, D. A. Stewart, T. Cheng, S. M. Lupichuk, M. J. Nodwell, J. A. Russell, I. A. Auer, and D. G. Morris. 2003. Reovirus oncolysis as a novel purging strategy for autologous stem cell transplantation. Blood 102:377-387.
47. Toth, M., and A. Honty. 1966. Age-incidence of haemagglutination-inhibiting antibodies to reovirus types 1, 2 and 3. Acta Microbiol. Acad. Sci. Hung. 13:119-125.
48. Twigger, K., L. Vidal, C. L. White, J. S. De Bono, S. Bhide, M. Coffey, B. Thompson, R. G. Vile, L. Heinemann, H. S. Pandha, F. Errington, A. A. Melcher, and K. J. Harrington. 2008. Enhanced in vitro and in vivo cytotoxicity of combined reovirus and radiotherapy. Clin. Cancer Res. 14:912-923.
49. Vandesompele, J., A. De Paepe, and F. Speleman. 2002. Elimination of primer-dimer artifacts and genomic coamplification using a two-step SYBR green I real-time RT-PCR. Anal. Biochem. 303:95-98.
50. Vandesompele, J., K. De Preter, F. Pattyn, B. Poppe, N. Van Roy, A. De Paepe, and F. Speleman. 2002. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3:RESEARCH0034.
51. Virgin, H. W., T. S. Dermody, and K. L. Tyler. 1998. Cellular and humoral immunity to reovirus infection. Curr. Top. Microbiol. Immunol. 233:147-161.
52. Virgin, H. W., IV, M. A. Mann, B. N. Fields, and K. L. Tyler. 1991. Monoclonal antibodies to reovirus reveal structure/function relationships between capsid proteins and genetics of susceptibility to antibody action. J. Virol. 65:6772-6781.
53. Virgin, H. W., IV, and K. L. Tyler. 1991. Role of immune cells in protection against and control of reovirus infection in neonatal mice. J. Virol. 65:5157-5164.
54. + T cell responses. Curr. Opin. Immunol. 12:448-455.
55. Wu, Y., and Y. Liu. 1994. Viral induction of co-stimulatory activity on antigen-presenting cells bypasses the need for CD4+- T-cell help in CD8+-T-cell responses. Curr. Biol. 4:499-505.